Childrens Flanax Oral Suspension
NDC Package 27854-777-99

11-digit billing NDC: 27854077799

Package Information

Childrens Flanax Oral (ibuprofen) suspension is • this product does not contain directions or complete warnings for adult use• do not give more than directed • shake well before using • mL = milliliter • find right dose on chart. This formulation utilizes a suspension delivery system. Marketed by Belmora Llc, this product is identified by NDC 27854-777 and is authorized under FDA application ANDA209179.

Identification & Billing

NDC Package Code
27854-777-99
Package Description
1 BOTTLE in 1 CARTON / 120 mL in 1 BOTTLE
Product Code
11-Digit Billing Format
27854077799
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Childrens Flanax Oral
Non-Proprietary Name
Ibuprofen
Substance Name
Ibuprofen
Dosage Form
Suspension - A liquid1 dosage form that contains solid particles dispersed in a liquid vehicle.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
Usage Information
• this product does not contain directions or complete warnings for adult use• do not give more than directed • shake well before using • mL = milliliter • find right dose on chart. If possible, use weight to dose; otherwise use age. • use only enclosed dosing cup. Do not use any other dosing device. • if needed, repeat dose every 6 to 8 hours • do not use more than 4 times a day • replace original bottle cap to maintain child resistance • wash dosage cup after each use Dosing ChartWeight (lb)Age (year) Dose (mL)* under 24 lbsunder 2 years ask a doctor 24-35 lbs  2-3 years5 mL 36-47 lbs 4-5 years 7.5 mL 48-59 lbs  6-8 years10 mL  60-71 lbs 9-10 years12.5 mL  72-95 lbs 11 years15 mL * or as directed by a doctor

Regulatory & Marketing

Labeler Name
Belmora Llc
Product Type
Human Otc Drug
FDA Application #
ANDA209179
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
01-26-2024
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 27854-777-99 identifies a specific commercial package of 1 bottle in 1 carton / 120 ml in 1 bottle of Childrens Flanax Oral, a human over the counter drug labeled by Belmora Llc. This suspension is formulated for oral use and contains ibuprofen as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Belmora Llc on January 26, 2024. The current certification is valid through December 31, 2027.

How is this Belmora Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 27854077799. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
27854-777-99
11-Digit CMS (5-4-2)
27854-0777-99

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.